PMC9647311_01
A 20-year-old male with multibacillary Hansen's disease (nodular lepromatous)
treated with monthly rifampin, minocycline, and moxifloxacin and
demonstrated rapid clinical improvement of skin nodules and plaques. This
patient completed a 24-month course of monthly ROM with adequate adherence
to the regimen and no adverse events without evidence of skin lesions or
hyperpigmentation.
10.1177_20499361221135885-fig2.jpg
PMC9647311_01_10.1177_20499361221135885-fig2.jpg
fig2-20499361221135885
All providers reported consistent and rapid clearance of skin lesions with definite clinical improvement observed (Figures 2-4).
A 72-year-old female with multibacillary Hansen's disease (nodular
lepromatous) treated with monthly rifampin, minocycline, and moxifloxacin,
and demonstrated clinical improvement in the size and appearance of the
plaques. This patient completed a 12-month ROM with adequate adherence to
the regimen and no adverse events without evidence of skin lesions or
hyperpigmentation.
10.1177_20499361221135885-fig3.jpg
PMC9647311_01_10.1177_20499361221135885-fig3.jpg
fig3-20499361221135885
All providers reported consistent and rapid clearance of skin lesions with definite clinical improvement observed (Figures 2-4).
A 70-year-old male with multibacillary Hansen's disease (borderline
lepromatous leprosy) treated with rifampin, minocycline, and moxifloxacin
demonstrating substantial improvement after 24 months of therapy.
10.1177_20499361221135885-fig4.jpg
PMC9647311_01_10.1177_20499361221135885-fig4.jpg
fig4-20499361221135885
All providers reported consistent and rapid clearance of skin lesions with definite clinical improvement observed (Figures 2-4).